Current status of antiangiogenic factors.
Talks
K L
KL
Growth Factors Group, ICRF Medical Oncology Unit, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK.
Harris
A L
AL
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000818:Animals; D002986:Clinical Trials as Topic; D016147:Genes, Tumor Suppressor; D015316:Genetic Therapy; D006801:Humans; D000860:Hypoxia; D009369:Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics; D009389:Neovascularization, Pathologic / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics; D009857:Oncogenes
D020533:Angiogenesis Inhibitors